Lemon Tart is a modern hybrid-indica strain developed through the deliberate crossing of G-13 and Golden Lemons. Cultivated for consistent performance, the plant demonstrates a moderate level of difficulty that makes it suitable for both indoor and outdoor environments. Growers can expect a high yield from this variety, which reaches maturity after a 65-day flowering period. Its genetic influence remains a significant part of contemporary breeding, most notably evidenced by its role in the development of its offspring, Sweet Candy Breath.

The sensory profile of Lemon Tart is defined by a complex chemical composition, led by a dominant concentration of terpinolene, followed closely by caryophyllene and limonene. The aromatic and flavor nuances are rounded out by the presence of ocimene, linalool, myrcene, humulene, pinene, beta-pinene, and nerolidol. Further analysis reveals trace amounts of caryophyllene-oxide, eucalyptol, bisabolol, camphene, alpha-terpinene, gamma-terpinene, and isopulegol. This specific terpene hierarchy ensures a balanced experience that reflects the strain's intricate botanical lineage.

As a THC-dominant variety, Lemon Tart consistently produces effects defined by a relaxed, calm, and focused mental state. These characteristics make it a functional choice for users seeking support in managing pain, stress, and sleep. The overall profile emphasizes utility and balance, bridging the gap between physical relief and cognitive clarity. This reliable therapeutic potential has established Lemon Tart as a staple within modern hybrid-indica circles.